Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stomach Neoplasms 13 Ovarian Neoplasms 9 Peritoneal Neoplasms 8 Carcinoma, Ovarian Epithelial 6 Fallopian Tube Neoplasms 5 Colorectal Neoplasms 4 Mesothelioma 2 Carcinoma 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Stage Ⅲ Gastric Cancer 1 Stage IV Gastric Cancer With Metastasis 1 Pseudomyxoma Peritonei 1 Pleural Effusion 1 Peritoneal Cancer 1 Pancreatic Neoplasms 1 Ovarian Cancer Recurrent 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Locally Advanced Colorectal Cancer 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Exploratory Behavior 1 Drug-Related Side Effects and Adverse Reactions 1 Ascites 1 Appendiceal Neoplasms 1 Advanced Gastric Adenocarcinoma 1

Interventions

Oxaliplatin 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Peritoneal Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡